WIN Consortium Appoints Winston and Strawn LLP as Official Legal Counsel
PARIS--(BUSINESS WIRE)--The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine, www.winconsortium.org is proud to announce Winston and Strawn LLP (www.winston.com) has been appointed as their official legal advisor. WIN is a global network of leading academic, industry, payors and patient advocacy organizations working to make precision cancer care a reality for patients worldwide. WIN’s goal is to significantly improve survival and quality of life of cancer patients in the next three years. Today WIN counts 32 members in 5 continents :
“We are thrilled that all members adhered to the consortium agreement”
1. 19 academic cancer centers across the globe, representing a diversity
of populations of which: MDAnderson Cancer Center, Houston (MDACC);
University of California San Diego (UCSD); New York University Langone
Medical Cancer Centre (NYUCC), USA; McGill University Segal Cancer
Center, Canada; Barretos, Brazil; Institut Gustave Roussy, France; DKFZ
German Cancer Research Center (DKFZ), Germany; Instituto Nazionale dei
Tumori (INT) & Istituto Europeo di Oncologia, (IEO) Italy; Vall d’Hebron
(VHIO) Spain; Hadassah University, Chaim Sheba Medical Center &
Ben-Gurion University of the Negev, Israel; University of Medicine and
Pharmacy (UMF) and Oncology Institute Ion Chiricuta (IOCN), Romania;
King Hussein Cancer Center (KHCC), Jordan; Fudan University Shanghai
Cancer Center, China; Advanced Centre for Treatment, Research and
Education in Cancer (ACTREC) India; National Cancer Center (NCC)
Singapore and Semmelweis University, Hungary.
2. Pharmaceutical companies and technology: Pfizer Inc., AstraZeneca & Millennium Takeda, Foundation Medicine, Oracle, GE Healthcare, Agilent and Life Technologies
3. Healthplan: Blue Cross Blue Shield Association, USA
4. Patient advocacy: National Breast Cancer Foundation, USA
5. Non-profit research organization: Sage Bionetworks, EORTC
Dr. Vladimir Lazar, Founder and Chief Operating Officer of WIN Consortium stated: ‘’WIN was formed on the premise that WIN members can accomplish together what no single Institution or group of patients can do alone. To achieve this strategic goal, Winston & Strawn LLP Paris partner Jérôme Herbet and associate Rim Khirddine provided invaluable assistance in setting up a consortium agreement ratified by the 32 member institutions worldwide”.
“We are thrilled that all members adhered to the consortium agreement” stated Gilles Bigot, Managing Partner of the Paris office of Winston and Strawn LLP. ‘’The agreement should help the WIN Consortium achieve its ambitious projects. We are proud to become the official legal advisors of WIN, a unique model of worldwide cooperation between all stakeholders of cancer care’’ added Gilles Bigot.